Detalles de la búsqueda
1.
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world: The retrospective IMAGE study.
Eur J Haematol
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38712850
2.
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Haematologica
; 108(10): 2774-2782, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37078253
3.
High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Blood
; 135(16): 1396-1405, 2020 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31978225
4.
Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
Transfusion
; 62(5): 961-973, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35452143
5.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol
; 189(1): 84-96, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702836
6.
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes.
Haematologica
; 104(3): 497-504, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287621
7.
Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.
Br J Haematol
; 164(5): 710-6, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24344981
8.
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
J Clin Oncol
; 42(14): 1612-1618, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38364196
9.
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood Adv
; 8(2): 296-308, 2024 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37874913
10.
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
J Clin Oncol
; 41(19): 3523-3533, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071836
11.
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).
J Clin Oncol
; 40(3): 242-251, 2022 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843406
12.
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
J Clin Oncol
; 40(28): 3239-3245, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947804
13.
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Blood Adv
; 5(16): 3227-3239, 2021 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427583
14.
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older.
J Clin Oncol
; 39(11): 1203-1213, 2021 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33444079
15.
[Carfilzomib-induced haemolytic and uremic syndrome: Favorable outcome with eculizumab]. / Syndrome hémolytique et urémique lié au carfilzomib: évolution favorable sous éculizumab.
Nephrol Ther
; 16(4): 221-224, 2020 Jul.
Artículo
en Francés
| MEDLINE | ID: mdl-32571738
16.
Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study.
Blood Adv
; 4(14): 3217-3223, 2020 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673385
17.
Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived.
Eur J Haematol
; 83(5): 449-54, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19519727
18.
Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available.
Leuk Lymphoma
; 60(14): 3493-3502, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31359808
19.
Myelofibrosis and acquired hemophilia A: a case report.
J Med Case Rep
; 10(1): 115, 2016 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27154067
20.
Nucleophosmin gene-based monitoring in de novo cytogenetically normal acute myeloid leukemia with nucleophosmin gene mutations: comparison with cytofluorimetric analysis and study of Wilms tumor gene 1 expression.
Leuk Lymphoma
; 53(11): 2214-7, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22475129
Resultados
1 -
20
de 20
1
Próxima >
>>